Literature DB >> 8331037

Mucus hypersecretion and eosinophils in bronchoalveolar lavage fluid in adult patients with bronchial asthma.

Y Tanizaki1, H Kitani, M Okazaki, T Mifune, F Mitsunobu, I Kimura.   

Abstract

Mucus hypersecretion was clinically analyzed in 46 adult patients with bronchial asthma, including 22 with steroid-dependent intractable asthma (SDIA). A large amount of expectoration, over 50 ml/day, was observed in 16 of these patients (34.8%), of whom 12 (75.0%) had SDIA and 13 (81.3%) were women. The mean amount of expectoration increased with increasing patient age, although no significant difference was found among the six age groups. A large amount of expectoration (over 50 ml/day) was clearly correlated with an increased proportion of eosinophils in bronchoalveolar lavage (BAL) fluid. The proportion of BAL eosinophils was significantly higher in patients with expectoration between 50 and 99 ml/day (p < 0.05) and over 100 ml/day (p < 0.01) than in patients whose expectoration volume was between 30 and 49 ml/day. These results show that in bronchial asthma patients, mucus hypersecretion is more often observed clinically in those with SDIA and in women, and that this hypersecretion is closely correlated with BAL eosinophilia, which is a feature of the pathophysiological changes that occur in the airways of these patients.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8331037     DOI: 10.3109/02770909309054525

Source DB:  PubMed          Journal:  J Asthma        ISSN: 0277-0903            Impact factor:   2.515


  6 in total

1.  Quantitative assessment of airway remodelling and response to allergen in asthma.

Authors:  David C Adams; Alyssa J Miller; Matthew B Applegate; Josalyn L Cho; Daniel L Hamilos; Alex Chee; Jasmin A Holz; Margit V Szabari; Lida P Hariri; R Scott Harris; Jason W Griffith; Andrew D Luster; Benjamin D Medoff; Melissa J Suter
Journal:  Respirology       Date:  2019-03-07       Impact factor: 6.424

2.  Mitochondrial dysfunction increases allergic airway inflammation.

Authors:  Leopoldo Aguilera-Aguirre; Attila Bacsi; Alfredo Saavedra-Molina; Alexander Kurosky; Sanjiv Sur; Istvan Boldogh
Journal:  J Immunol       Date:  2009-09-28       Impact factor: 5.422

3.  Pathogenesis of mucous cell metaplasia in a murine asthma model.

Authors:  J Rachel Reader; Jeffrey S Tepper; Edward S Schelegle; Melinda C Aldrich; Lei F Putney; Juergen W Pfeiffer; Dallas M Hyde
Journal:  Am J Pathol       Date:  2003-06       Impact factor: 4.307

4.  High frequency chest wall oscillation for asthma and chronic obstructive pulmonary disease exacerbations: a randomized sham-controlled clinical trial.

Authors:  Amit K Mahajan; Gregory B Diette; Umur Hatipoğlu; Andrew Bilderback; Alana Ridge; Vanessa Walker Harris; Vijay Dalapathi; Sameer Badlani; Stephanie Lewis; Jeff T Charbeneau; Edward T Naureckas; Jerry A Krishnan
Journal:  Respir Res       Date:  2011-09-10

5.  VEGF receptor 2 (KDR) protects airways from mucus metaplasia through a Sox9-dependent pathway.

Authors:  Ming Jiang; Yinshan Fang; Yu Li; Huachao Huang; Zichen Wei; Xia Gao; Hoon-Ki Sung; Jim Hu; Li Qiang; Jian Ruan; Qixuan Chen; Dianhua Jiang; Jeffrey A Whitsett; Xingbin Ai; Jianwen Que
Journal:  Dev Cell       Date:  2021-05-18       Impact factor: 13.417

6.  Induction of airway mucus production By T helper 2 (Th2) cells: a critical role for interleukin 4 in cell recruitment but not mucus production.

Authors:  L Cohn; R J Homer; A Marinov; J Rankin; K Bottomly
Journal:  J Exp Med       Date:  1997-11-17       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.